Your browser doesn't support javascript.
loading
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
Murphy, J Patrick; Kim, Youra; Clements, Derek R; Konda, Prathyusha; Schuster, Heiko; Kowalewski, Daniel J; Paulo, Joao A; Cohen, Alejandro M; Stevanovic, Stefan; Gygi, Steven P; Gujar, Shashi.
Afiliação
  • Schuster H; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany.
  • Kowalewski DJ; Immatics Biotechnologies GmbH , 72076 Tübingen , Germany.
  • Paulo JA; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany.
  • Cohen AM; Immatics Biotechnologies GmbH , 72076 Tübingen , Germany.
  • Stevanovic S; Department of Cell Biology , Harvard Medical School , Boston , Massachusetts 02115 , United States.
  • Gujar S; Department of Immunology, Interfaculty Institute for Cell Biology , University of Tübingen , 72074 Tübingen , Germany.
J Proteome Res ; 18(6): 2666-2675, 2019 06 07.
Article em En | MEDLINE | ID: mdl-31095916

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteômica / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteômica / Vírus Oncolíticos / Terapia Viral Oncolítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article